CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80.96% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Aurora Cannabis management commentary cites higher adjusted SG&A as driver of Q2 fiscal 2027 adjusted EBITDA decline

By Public Technologies
  • Aurora Cannabis management commentary attributed second-quarter fiscal 2027 adjusted EBITDA's decline to $14 million from $15.4 million to higher selling costs.
  • International medical cannabis net revenue rose to $61.4 million, driven by stronger patient demand in Germany and Poland.
  • Canadian medical cannabis net revenue fell to $21.2 million as reimbursement cuts reduced revenue; medical adjusted gross margin narrowed to 62%.
  • Net loss from continuing operations narrowed to $21.1 million from $27.2 million, primarily reflecting prior-year impairments and higher gross profit.
  • Free cash outflow decreased to $17.5 million from $39.9 million, primarily reflecting lower working capital investment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurora Cannabis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-070546), on November 05, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.